Double Medical(SZ:002901) Sou Hu Cai Jing·2026-02-03 12:37Core Viewpoint - Dabo Medical (002901) shows a positive trend in stock performance and financial metrics, indicating potential growth opportunities in the medical device industry. Financial Performance - As of February 3, 2026, Dabo Medical's stock closed at 49.75 yuan, up 1.12%, with a trading volume of 18,500 lots and a transaction value of 91.64 million yuan [1] - For the first three quarters of 2025, the company reported a main revenue of 1.876 billion yuan, a year-on-year increase of 22.69%, and a net profit of 425 million yuan, up 77.03% year-on-year [2] - The company's gross profit margin stands at 71.23%, significantly higher than the industry average of 50.55% [2] Market Position - Dabo Medical has a total market capitalization of 20.597 billion yuan, ranking 12th in the medical device industry [2] - The company has a price-to-earnings ratio (P/E) of 36.38, which is lower than the industry average of 97.37, indicating a potentially undervalued stock [2] - The return on equity (ROE) is 12.83%, placing the company 8th in the industry, which reflects strong profitability compared to peers [2] Recent Trading Activity - On February 3, 2026, the net outflow of main funds was 2.7838 million yuan, while retail investors saw a net inflow of 1.1964 million yuan [1] - Over the past five days, the stock has experienced fluctuations in fund flows, with notable retail interest despite some institutional selling [1]